BioSpace News Archive

Melior Pharmaceuticals I, Inc announced that its novel first-in-class insulin sensitizer, tolimidone, has demonstrated significant reduction of HbA1c compared to placebo in a recently completed Phase 2B study involving patients with Type 2 diabetes mellitus in an analysis of all subjects who completed the full course of treatment.

TISSIUM branding reflects broader focus on tissue reconstruction

Surgical implant maker Xenco Medical has announced the launch of the first interactive vending machines designed for spine surgery instruments and implants.

Heron Therapeutics, Inc. announced results of a multi-center postoperative pain management study in 93 patients that provides real-world evidence of opioid-free recovery in patients undergoing outpatient inguinal hernia repair surgery who received the investigational agent, HTX-011, together with a scheduled background regimen of generic over-the-counter oral analgesics.

New medical approach allows comprehensive preventative care based on a patient’s individual genetic makeup, environment and lifestyle.

ValGenesis will continue to strengthen its presence in this region to better serve customer expectations of best-in-class digital validation lifecycle solutions and delivery.

The Illinois Mesothelioma Victims Center is offering to assist a US Navy Veteran with mesothelioma anywhere in Illinois who was exposed to asbestos on a nuclear-powered aircraft carrier, a fast-attack submarine, a Poseidon-class, or Ohio-class submarine with the goal being the best possible financial compensation results.

Well iQ encourages patient feedback and employee engagement, can optimize reimbursements for healthcare providers

The assets will be grouped together as one all-inclusive auction lot to be sold to the highest bidder.

James Wiskin, Ph.D, QT Ultrasound’s Principal Scientist, invited to lecture on innovative technology